Cover Image
市場調查報告書

介入心臟病學及末梢血管設備的全球市場:各產品:機會分析與產業預測

World Interventional Cardiology & Peripheral Vascular Devices Market by Product - Global Opportunity Analysis and Industry Forecast, 2014-2022

出版商 Allied Market Research 商品編碼 398925
出版日期 內容資訊 英文 130 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
介入心臟病學及末梢血管設備的全球市場:各產品:機會分析與產業預測 World Interventional Cardiology & Peripheral Vascular Devices Market by Product - Global Opportunity Analysis and Industry Forecast, 2014-2022
出版日期: 2016年10月01日 內容資訊: 英文 130 Pages
簡介

本報告提供全球介入心臟病學及末梢血管設備的相關調查,彙整市場各產品,各地區趨勢,及加入此市場的主要供應商簡介等資料。

第1章 簡介

第2章 摘要整理

第3章 市場概要

  • 市場定義和範圍
  • 主要調查結果
  • 市場佔有率分析:2015年
  • 市場趨勢
    • 促進要素
    • 阻礙要素
    • 機會
  • 臨床實驗

第4章 各產品市場

  • 概要
  • 血管新生球囊
  • 血管新生支架
  • 血管新生導管
  • 血管內動脈瘤修復血管支架
  • 下腔靜脈濾器
  • 血小板修飾設備
  • 血液動態血流變更設備
  • 配件

第5章 各地區市場

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 南美·中東·非洲

第6章 企業簡介

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • C. R. Bard, Inc.
  • Cardinal Health, Inc.
  • Cook Medical, Inc.
  • Medtronic plc
  • St. Jude Medical, Inc.
  • Terumo Corporation
  • The Spectranetics Corporation

圖表

目錄
Product Code: LI 161072

Interventional cardiology is a branch of cardiology that focuses on catheter-based technologies for the treatment of structural heart diseases. Catheterization is used to perform large number of procedures on heart. It involves the insertion of a sheath into the femoral artery or any large peripheral artery or vein, and cannulating the heart under X-ray visualization (commonly known as fluoroscopy). However, numerous interventional devices are used for treating peripheral vascular disorders that affect the circulatory system, resulting in plaque built-up in the arteries of arms and legs. Some of the interventional devices used in the market include balloons, catheters, guidewires, stents, and filters.

The world interventional cardiology & peripheral vascular devices market was $13,203 million in 2015 and is expected to reach $25,349 million by 2022 with a CAGR of 9.7%. Rise in prevalence of cardiovascular disorders, geriatric population, demand for minimally invasive procedures, and rapid technological advancements in these devices driven the market. According to the American Heart Association, approximately 5.5 million individuals are affected by heart failure in the U.S., and approximately 670,000 new cases of heart failure are diagnosed every year. According to the Heart & Stroke Foundation, Canada, approximately 66,000 Canadians succumbed to cardiac abnormalities and stroke in 2012. These estimates are expected to boost the demand for interventional cardiology & peripheral vascular devices in the coming years.

On the other hand, complications related to implantation of interventional cardiology & peripheral vascular devices, product recall & failure, and availability of effective conventional treatment options restrict the market growth. Conversely, development of bioabsorbable stents offers key opportunity to market players. Unfavorable reimbursement policies for interventional cardiology & peripheral vascular devices across various regions (mainly the developing countries) are major hindrances for the market growth.

The report segments the market based on product and geography. Based on product, the market is classified into angioplasty balloons, angioplasty stents, angioplasty catheters, endovascular aneurysm repair stent grafts, inferior vena cava (IVC) filters, plaque modification devices, hemodynamic flow alteration devices, and accessories. Angioplasty stents accounted for the major share of market in 2015; whereas plaque modification devices are the fastest growing segment during the forecast period. Plaque modification before a stent implant decreases the chance of restenosis. In addition, increase in prevalence of atherosclerosis and rise in obese population globally also fuel growth of these devices. Based on geography, the market is divided into North America, Europe, Asia-Pacific, and LAMEA regions North America accounted for the major share of the overall market in 2015, and Asia-Pacific is expected to be the fastest growing segment during the analysis period.

The market has witnessed several product launches and approvals in the recent years. For instance, in July 2016, Abbott Laboratories received FDA approval for Absorb bioresorbable heart stent. Absorb is a fully dissolvable stent for treatment of coronary artery diseases. This product launch not only enhanced the company's vascular business, but also provided a better treatment option for blocked vessels of heart.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate the imminent investment pockets.
  • The report provides a quantitative analysis for the period of 2014-2022 to enable stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the market based on product helps understand the type of devices used for treating blockages associated with chronic diseases.
  • Competitive intelligence highlights the business practices followed by leading players across various regions.
  • Comprehensive analysis of all geographic regions helps determine the prevailing opportunities in these regions.
  • Key market players and their strategies are analyzed to understand the competitive outlook of the global market.
  • Extensive analysis of the market is conducted by following key product positioning and monitoring the top contenders within the market framework.

KEY MARKET SEGMENTS:

By Product

  • Angioplasty Balloons
  • Old/Normal Balloons
  • Cutting and Scoring Balloons
  • Drug-eluting Balloons
  • Angioplasty Stents
  • Drug-eluting Stents
  • Bare Metal Stents
  • Bioabsorbable Stents
  • Angioplasty Catheters
  • Angiography Catheters
  • Guiding Catheters
  • Endovascular Aneurysm Repair Stent Grafts
  • Abdominal Aortic Aneurysm
  • Thoracic Aortic Aneurysm
  • Inferior Vena Cava (IVC) Filters
  • Retrievable Filters
  • Permanent Filters
  • Plaque Modification Devices
  • Thrombectomy Devices
  • Atherectomy Devices
  • Hemodynamic Flow Alteration Devices
  • Embolic Protection Devices
  • Chronic Total Occlusion Devices
  • Accessories
  • Vascular Closure Devices
  • Introducer Sheaths
  • Guidewires
  • Balloon Inflation Devices

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Malaysia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Egypt
    • Rest of LAMEA

Table of Contents

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key benefits
  • 1.3. Key market segments
  • 1.4. Key players
  • 1.5. Research methodology
    • 1.5.1. Secondary research
    • 1.5.2. Primary research
    • 1.5.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top investment pockets
    • 3.2.2. Top winning strategies
      • 3.2.2.1. Competitive intelligence of companies and their strategies
  • 3.3. Market share analysis, 2015
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Growing geriatric population and increasing prevalence of chronic diseases
      • 3.4.1.2. Technological advancements
      • 3.4.1.3. Improving healthcare infrastructure in developing countries
      • 3.4.1.4. Development of minimally invasive procedures
      • 3.4.1.5. Increasing patient awareness
    • 3.4.2. Restraints
      • 3.4.2.1. High treatment cost
      • 3.4.2.2. Stringent approval process for interventional cardiology and peripheral vascular devices
    • 3.4.3. Opportunities
      • 3.4.3.1. Huge market opportunities in developing countries
      • 3.4.3.2. Development of Bioabsorbable stents
  • 3.5. Clinical Trials

CHAPTER 4: WORLD INTERVENTIONAL CARDIOLGY & PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Angioplasty Balloons
    • 4.2.1. Old/Normal balloons
    • 4.2.2. Cutting and scoring balloons
    • 4.2.3. Drug eluting balloons
    • 4.2.4. Key market trends
    • 4.2.5. Key growth factors and opportunities
    • 4.2.6. Market size and forecast
  • 4.3. Angioplasty Stents
    • 4.3.1. Coronary stents
      • 4.3.1.1. Bare-metal stents
      • 4.3.1.2. Drug-eluting stents (DES)
      • 4.3.1.3. Bioabsorbable stents
    • 4.3.2. Peripheral stents
    • 4.3.3. Key market trends
    • 4.3.4. Key growth factors and opportunities
    • 4.3.5. Market size and forecast
  • 4.4. Angioplasty Catheters
    • 4.4.1. Angiography Catheters
    • 4.4.2. Guiding Catheters
    • 4.4.3. Key market trends
    • 4.4.4. Key growth factors and opportunities
    • 4.4.5. Market size and forecast
  • 4.5. Endovascular Aneurysm Repair Stent Grafts
    • 4.5.1. Abdominal aortic aneurysm
    • 4.5.2. Thoracic aortic aneurysm
    • 4.5.3. Key market trends
    • 4.5.4. Key growth factors and opportunities
    • 4.5.5. Market size and forecast
  • 4.6. Inferior Vena Cava (IVC) Filters
    • 4.6.1. Permanent filters
    • 4.6.2. Retrievable filters
    • 4.6.3. Key market trends
    • 4.6.4. Key growth factors and opportunities
    • 4.6.5. Market size and forecast
  • 4.7. Plaque Modification Devices
    • 4.7.1. Thrombectomy devices
    • 4.7.2. Atherectomy devices
    • 4.7.3. Key market trends
    • 4.7.4. Key growth factors and opportunities
    • 4.7.5. Market size and forecast
  • 4.8. Hemodynamic Flow Alteration Devices
    • 4.8.1. Embolic protection devices
    • 4.8.2. Chronic total occlusion devices
    • 4.8.3. Key market trends
    • 4.8.4. Key growth factors and opportunities
    • 4.8.5. Market size and forecast
  • 4.9. Accessories
    • 4.9.1. Vascular closure devices
    • 4.9.2. Introducer sheaths
    • 4.9.3. Guidewires
    • 4.9.4. Balloon inflation devices
    • 4.9.5. Key market trends
    • 4.9.6. Key growth factors and opportunities
    • 4.9.7. Market size and forecast

CHAPTER 5: WORLD INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY GEOGRAPHY, 2014-2022

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. North America
    • 5.2.1. Key market trends
    • 5.2.2. Key growth factors and opportunities
    • 5.2.3. Market size and forecast
    • 5.2.4. U.S. market size and forecast
    • 5.2.5. Canada market size and forecast
    • 5.2.6. Mexico market size and forecast
  • 5.3. Europe
    • 5.3.1. Key market trends
    • 5.3.2. Key growth factors and opportunities
    • 5.3.3. Market size and forecast
    • 5.3.4. Germany market size and forecast
    • 5.3.5. France market size and forecast
    • 5.3.6. U.K. market size and forecast
    • 5.3.7. Italy market size and forecast
    • 5.3.8. Spain market size and forecast
    • 5.3.9. Rest of Europe market size and forecast
  • 5.4. Asia-Pacific
    • 5.4.1. Key market trends
    • 5.4.2. Key growth factors and opportunities
    • 5.4.3. Market size and forecast
    • 5.4.4. Japan market size and forecast
    • 5.4.5. China market size and forecast
    • 5.4.6. India market size and forecast
    • 5.4.7. Malaysia market size and forecast
    • 5.4.8. Australia market size and forecast
    • 5.4.9. Rest of Asia-Pacific market size and forecast
  • 5.5. LAMEA
    • 5.5.1. Key market trends
    • 5.5.2. Key growth factors and opportunities
    • 5.5.3. Market size and forecast
    • 5.5.4. Brazil market size and forecast
    • 5.5.5. South Africa market size and forecast
    • 5.5.6. Egypt market size and forecast
    • 5.5.7. Rest of LAMEA market size and forecast

CHAPTER 6: COMPANY PROFILES

  • 6.1. Abbott Laboratories
    • 6.1.1. Company Overview
    • 6.1.2. Company Snapshot
    • 6.1.3. Operating Business Segments
    • 6.1.4. Business Performance
    • 6.1.5. Key Strategic Moves & Developments
  • 6.2. B. Braun Melsungen AG
    • 6.2.1. Company Overview
    • 6.2.2. Company Snapshot
    • 6.2.3. Operating Business Segments
    • 6.2.4. Business Performance
    • 6.2.5. Key Strategic Moves & Developments
  • 6.3. Boston Scientific Corporation
    • 6.3.1. Company Overview
    • 6.3.2. Company Snapshot
    • 6.3.3. Operating Business Segments
    • 6.3.4. Business Performance
    • 6.3.5. Key Strategic Moves & Developments
  • 6.4. C. R. Bard, Inc.
    • 6.4.1. Company Overview
    • 6.4.2. Company Snapshot
    • 6.4.3. Operating Business Segments
    • 6.4.4. Business Performance
    • 6.4.5. Key Strategic Moves & Developments
  • 6.5. Cardinal Health, Inc.
    • 6.5.1. Company Overview
    • 6.5.2. Company Snapshot
    • 6.5.3. Operating Business Segments
    • 6.5.4. Business Performance
    • 6.5.5. Key Strategic Moves & Developments
  • 6.6. Cook Medical, Inc.
    • 6.6.1. Company Overview
    • 6.6.2. Company Snapshot
    • 6.6.3. Operating Business Segments
    • 6.6.4. Key Strategic Moves & Developments
  • 6.7. Medtronic plc
    • 6.7.1. Company Overview
    • 6.7.2. Company Snapshot
    • 6.7.3. Operating Business Segments
    • 6.7.4. Business Performance
    • 6.7.5. Key Strategic Moves & Developments
  • 6.8. St. Jude Medical, Inc.
    • 6.8.1. Company Overview
    • 6.8.2. Company Snapshot
    • 6.8.3. Operating Business Segments
    • 6.8.4. Business Performance
    • 6.8.5. Key Strategic Moves & Developments
  • 6.9. Terumo Corporation
    • 6.9.1. Company Overview
    • 6.9.2. Company Snapshot
    • 6.9.3. Operating Business Segments
    • 6.9.4. Business Performance
    • 6.9.5. Key Strategic Moves & Developments
  • 6.10. The Spectranetics Corporation
    • 6.10.1. Company Overview
    • 6.10.2. Company Snapshot
    • 6.10.3. Operating Business Segments
    • 6.10.4. Business Performance
    • 6.10.5. Key Strategic Moves & Developments

List of Tables

  • TABLE 1: WORLD INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2014-2022 ($MILLION)
  • TABLE 2: WORLD ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2014-2022 ($MILLION)
  • TABLE 3: ANGIOPLASTY BALLOONS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 4: WORLD ANGIOPLASTY STENTS MARKET, BY TYPE, 2014-2022 ($MILLION)
  • TABLE 5: WORLD CORONARY STENTS MARKET, BY TYPE, 2014-2022 ($MILLION)
  • TABLE 6: ANGIOPLASTY STENTS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 7: WORLD ANGIOPLASTY CATHETERS MARKET, BY TYPE, 2014-2022 ($MILLION)
  • TABLE 8: ANGIOPLASTY CATHETERS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 9: WORLD ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS MARKET, BY TYPE, 2014-2022 ($MILLION)
  • TABLE 10: ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 11: TYPES OF IVC FILTERS AVAILABLE IN THE MARKET
  • TABLE 12: WORLD INFERIOR VENA CAVA (IVC) FILTERS MARKET, BY TYPE, 2014-2022 ($MILLION)
  • TABLE 13: INFERIOR VENA CAVA (IVC) FILTERS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 14: WORLD PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2014-2022 ($MILLION)
  • TABLE 15: PLAQUE MODIFICATION DEVICES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 16: WORLD HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2014-2022 ($MILLION)
  • TABLE 17: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 18: WORLD ACCESSORIES MARKET, BY TYPE, 2014-2022 ($MILLION)
  • TABLE 19: ACCESSORIES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 20: INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 21: NORTH AMERICA: INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2014-2022 ($MILLION)
  • TABLE 22: NORTH AMERICA: INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2014-2022 ($MILLION)
  • TABLE 23: EUROPE: INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2014-2022 ($MILLION)
  • TABLE 24: EUROPE: INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2014-2022 ($MILLION)
  • TABLE 25: ASIA-PACIFIC: INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2014-2022 ($MILLION)
  • TABLE 26: ASIA-PACIFIC: INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2014-2022 ($MILLION)
  • TABLE 27: LAMEA: INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2014-2022 ($MILLION)
  • TABLE 28: LAMEA: INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2014-2022 ($MILLION)
  • TABLE 29: ABBOTT: COMPANY SNAPSHOT
  • TABLE 30: ABBOTT: OPERATING SEGMENTS
  • TABLE 31: B. BRAUN: COMPANY SNAPSHOT
  • TABLE 32: B. BRAUN: OPERATING SEGMENTS
  • TABLE 33: BOSTON SCIENTIFIC: COMPANY SNAPSHOT
  • TABLE 34: BOSTON SCIENTIFIC: OPERATING SEGMENTS
  • TABLE 35: BARD: COMPANY SNAPSHOT
  • TABLE 36: BARD: OPERATING SEGMENTS
  • TABLE 37: CARDINAL HEALTH: COMPANY SNAPSHOT
  • TABLE 38: CARDINAL HEALTH: OPERATING SEGMENTS
  • TABLE 39: COOK MEDICAL: COMPANY SNAPSHOT
  • TABLE 40: COOK MEDICAL: DIVISIONS
  • TABLE 41: MEDTRONIC: COMPANY SNAPSHOT
  • TABLE 42: MEDTRONIC: OPERATING SEGMENTS
  • TABLE 43: ST. JUDE MEDICAL: COMPANY SNAPSHOT
  • TABLE 44: ST. JUDE MEDICAL: PRODUCT CATEGORIES
  • TABLE 45: TERUMO: COMPANY SNAPSHOT
  • TABLE 46: TERUMO: OPERATING SEGMENTS
  • TABLE 47: SPECTRANETICS: COMPANY SNAPSHOT
  • TABLE 48: SPECTRANETICS: OPERATING SEGMENTS

List of Figures

  • FIG. 1: WORLD INTERVENTIONAL CRDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2015 VS 2022, ($MILLION)
  • FIG. 2: INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET SEGMENTATION
  • FIG. 3: TOP INVESTMENT POCKETS
  • FIG. 4: TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2014-2016)
  • FIG. 5: TOP WINNING STRATEGIES: NATURE AND TYPE
  • FIG. 6: TOP COMPANIES AND THEIR STRATEGIES
  • FIG. 7: DETAILED STRUCTURE OF COMPANIES AND NATURE OF STRATEGIES
  • FIG. 8: DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES
  • FIG. 9: MARKET SHARE ANALYSIS, 2015
  • FIG. 10: TOP IMPACTING FACTORS: INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET
  • FIG. 11: CLINICAL TRIALS IN WORLD INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET
  • FIG. 12: CLINICAL TRIALS FOR INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES, (%)
  • FIG. 13: WORLD PERIPHERAL STENTS MARKET, BY TYPE, 2014-2022 ($MILLION)
  • FIG. 14: U.S. INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
  • FIG. 15: CANADA INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
  • FIG. 16: MEXICO INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
  • FIG. 17: GERMANY INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
  • FIG. 18: FRANCE INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
  • FIG. 19: U.K. INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
  • FIG. 20: ITALY INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
  • FIG. 21: SPAIN INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
  • FIG. 22: REST OF EUROPE INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
  • FIG. 23: JAPAN INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
  • FIG. 24: CHINA INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
  • FIG. 25: INDIA INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
  • FIG. 26: MALAYSIA INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
  • FIG. 27: AUSTRALIA INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
  • FIG. 28: REST OF ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
  • FIG. 29: BRAZIL INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
  • FIG. 30: SOUTH AFRICA INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
  • FIG. 31: EGYPT INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
  • FIG. 32: REST OF LAMEA INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
  • FIG. 33: ABBOTT: NET SALES, 2013-2015 ($MILLION)
  • FIG. 34: ABBOTT: NET SALES, BY SEGMENT, 2015 (%)
  • FIG. 35: ABBOTT: NET SALES, BY GEOGRAPHY, 2015 (%)
  • FIG. 36: ABBOTT: STRATEGY SHARE, (%)
  • FIG. 37: B. BRAUN: NET SALES, 2013-2015 ($MILLION)
  • FIG. 38: B. BRAUN: NET SALES, BY SEGMENT, 2015 (%)
  • FIG. 39: B. BRAUN: NET SALES, BY GEOGRAPHY, 2015 (%)
  • FIG. 40: BOSTON SCIENTIFIC: NET SALES, 2013-2015 ($MILLION)
  • FIG. 41: BOSTON SCIENTIFIC: NET SALES, BY SEGMENT, 2015 (%)
  • FIG. 42: BOSTON SCIENTIFIC: NET SALES, BY GEOGRAPHY, 2015 (%)
  • FIG. 43: BOSTON SCIENTIFIC: STRATEGY SHARE, (%)
  • FIG. 44: BARD: NET SALES, 2013-2015 ($MILLION)
  • FIG. 45: BARD: NET SALES, BY SEGMENT, 2015 (%)
  • FIG. 46: BARD: NET SALES, BY GEOGRAPHY, 2015 (%)
  • FIG. 47: CARDINAL HEALTH: NET SALES, 2014-2016 ($MILLION)
  • FIG. 48: CARDINAL HEALTH: NET SALES, BY SEGMENT, 2016 (%)
  • FIG. 49: CARDINAL HEALTH: NET SALES, BY GEOGRAPHY, 2016 (%)
  • FIG. 50: MEDTRONIC: NET SALES, 2014-2016 ($MILLION)
  • FIG. 51: MEDTRONIC: NET SALES, BY SEGMENT, 2016 (%)
  • FIG. 52: MEDTRONIC: NET SALES, BY GEOGRAPHY, 2016 (%)
  • FIG. 53: MEDTRONIC: STRATEGY SHARE, (%)
  • FIG. 54: ST. JUDE MEDICAL: NET SALES, 2013-2015 ($MILLION)
  • FIG. 55: ST. JUDE MEDICAL: NET SALES, BY PRINCIPLE PRODUCT CATEGORY, 2015 (%)
  • FIG. 56: ST. JUDE MEDICAL: NET SALES, BY GEOGRAPHY, 2015 (%)
  • FIG. 57: ST. JUDE MEDICAL: STRATEGY SHARE, (%)
  • FIG. 58: TERUMO: NET SALES, 2014-2016 ($MILLION)
  • FIG. 59: TERUMO: NET SALES, BY SEGMENT, 2016 (%)
  • FIG. 60: TERUMO: NET SALES, BY GEOGRAPHY, 2016 (%)
  • FIG. 61: TERUMO: STRATEGY SHARE, (%)
  • FIG. 62: SPECTRANETICS: NET SALES, 2013-2015 ($MILLION)
  • FIG. 63: SPECTRANETICS: NET SALES, BY SEGMENT, 2015 (%)
  • FIG. 64: SPECTRANETICS: NET SALES, BY PRODUCT LINE, 2015 (%)
  • FIG. 65: SPECTRANETICS: STRATEGY SHARE, (%)
Back to Top